NCT04567420 2025-10-16
DARE
Criterium, Inc.
Phase 2 Recruiting
Clinical Trials
7 trialsNCT03778931 2025-09-15
EMERALD
Stemline Therapeutics, Inc.
Phase 3 Completed
NCT06309615 2025-05-29
PDxBRUTILITY
Precise Dx, Inc.
Not yet recruiting
NCT06989450 2025-05-25
Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer
Sidekick Health
Phase NA Recruiting
NCT00556374 2023-07-27
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
Amgen
Phase 3 Completed
NCT03202446 2018-02-23
Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer
Eske Corporation S.A.C
Phase 3 Terminated
NCT00977379 2016-11-15
XERAD
Hoffmann-La Roche
Phase 2 Terminated